Advertisements
Home Investing in Stocks Aroa Biosurgery Insider Returns Down to NZ$223k as Stock Dips 10%

Aroa Biosurgery Insider Returns Down to NZ$223k as Stock Dips 10%

by Barbara

Aroa Biosurgery Limited (ASX:ARX) has experienced a 10.0% decline in stock value over the past week. Despite this recent drop, insiders who purchased shares in the past 12 months have not been deeply impacted, with their NZ$325.6k worth of shares now valued at NZ$548.9k, indicating a positive return on their investment.

Insider Transactions Over the Past Year

The most significant insider transaction occurred when Non-Executive Director Philip McCaw bought AU$176k worth of shares at AU$0.54 per share. However, the price at which he bought the shares was notably lower than the current share price of AU$0.72. While insider buying is generally viewed positively, this purchase doesn’t provide much insight into how insiders feel about the current share price, as it was made at a lower price point.

Advertisements

Throughout the past year, Aroa Biosurgery insiders have not sold any shares. On average, shares were purchased at AU$0.43, which is a relatively favorable sign of their confidence in the company.

Advertisements

Insider Ownership

Insiders currently hold 25% of Aroa Biosurgery’s shares, valued at approximately AU$62 million. While this level of ownership is good, it falls short of being particularly notable, yet it does suggest a reasonable degree of alignment between the company’s leadership and shareholders.

Advertisements

What Do the Insider Transactions Indicate?

The absence of recent insider transactions doesn’t raise concerns, and the overall insider buying activity in the past year is viewed positively. The stake insiders have in Aroa Biosurgery aligns their interests with the company’s performance, contributing to overall confidence. While past transactions don’t necessarily predict future performance, the company’s outlook remains worth monitoring. For those interested, it would be beneficial to explore the company’s future forecasts through analyst reports.

Advertisements

Investors interested in Aroa Biosurgery can explore this free report on analyst forecasts, or consider reviewing a list of other companies with high return on equity and low debt for further opportunities.

Advertisements

Related topics:

Is It Good to Invest in Large Cap Mutual Funds

Is It Safe to Invest in Nfo

Advertisements

How Much to Invest in Unit Trust

You may also like

Rckir is a comprehensive financial portal. The main columns include foreign exchange wealth management, futures wealth management, gold wealth management, stock wealth management, fund wealth management, insurance wealth management, trust wealth management, wealth management knowledge, etc.

【Contact us: [email protected]

© 2023 Copyright Rckir.com [[email protected]]